1.. Introduction
================

Cigarette smoking is the most preventable cause of addiction, sickness and mortality in the world. Death attributed to cigarette smoking is estimated to rise from 5.4 million in 2005 to 6.4 million by 2015 \[[@b1-ijms-11-04488]\]. Chronic cigarette smoking is the single most important risk factor for lung and oral cancers, cardiovascular diseases, chronic obstructive pulmonary disease (COPD) and other tobacco related oral diseases, including periodontitis \[[@b2-ijms-11-04488]--[@b7-ijms-11-04488]\]. Cigarette smoke contains more than 60 carcinogens and around 4,000 chemicals, including bacteria-derived endotoxins, which are toxic to cells \[[@b8-ijms-11-04488]--[@b10-ijms-11-04488]\]. The risk of developing tobacco smoking-related diseases increases with the total exposure time to the cigarette smoke, which generally includes the number of cigarettes a person smokes each day and the number of years a person has been smoking \[[@b11-ijms-11-04488]\].

The oral cavity is the first organ in the human body to be exposed to the cigarette smoke. The tobacco smoke alters normal homeostasis of the oral cavity, including the saliva's antioxidant and other protective systems. This may lead to oral inflammatory diseases and oral cancers \[[@b12-ijms-11-04488]--[@b15-ijms-11-04488]\]. Early tumorigenic activities have been detected in normal oral mucosa of heavy smokers who have no overt precancerous or cancerous lesions \[[@b16-ijms-11-04488]\]. The mucosal changes in smokers may also arise from the drying effects of the mucosa, high intraoral temperatures, intraoral pH changes, local alteration of membrane barriers and immune responses, or altered resistance to bacteria, fungal and viral infections. Smoking-related cell damage may leave molecular footprints in the saliva, offering the potential for non-invasive early diagnosis of tobacco-related oral diseases.

Human saliva contains a large number of proteins and peptides that are easily accessible and may serve as a potential source of biomarkers to monitor changes that occur under pathological conditions. The value of saliva as a biological fluid for the detection of diagnostic and prognostic biomarkers has become increasingly well established \[[@b17-ijms-11-04488]--[@b24-ijms-11-04488]\]. Collection of human saliva is a simple, non-invasive and cost-effective approach for screening large populations. It is easy to handle and may be repeated without inflicting much discomfort to the subjects \[[@b17-ijms-11-04488],[@b18-ijms-11-04488]\].

Proteomic analysis is an important investigative tool used to systematically explore cellular proteins that are responsive to adverse environmental challenges. Several proteomic approaches, including those involving separation of proteins by two-dimensional electrophoresis (2-DE), have been applied in the investigation of biomarker candidates in the human saliva \[[@b25-ijms-11-04488]--[@b29-ijms-11-04488]\]. Recently, saliva has been shown to harbor potential informative biomarkers for oral cancer \[[@b30-ijms-11-04488]--[@b32-ijms-11-04488]\], head and neck cancer \[[@b33-ijms-11-04488],[@b34-ijms-11-04488]\], and breast cancer \[[@b35-ijms-11-04488]\]. While effects of the cigarette smoke on proteins expressed in the bronchoalveolar lavage \[[@b36-ijms-11-04488]--[@b38-ijms-11-04488]\], nasal lavage fluid \[[@b39-ijms-11-04488]\], urine \[[@b40-ijms-11-04488]\], lung tissue \[[@b41-ijms-11-04488]\], bronchial airway epithelium and pooled exhaled breath condensate samples \[[@b42-ijms-11-04488]\] have been analyzed, little information is available regarding the effects of smoking on the whole saliva proteome.

To the best of our knowledge, there had been no reported studies that specifically compared the expression of proteins in the saliva of smokers and non-smokers. In this study, 2-DE-based proteomics was used to screen for saliva proteins of differential abundance between smokers and subjects who had never smoked. The aberrantly expressed proteins, when correlated to those similarly altered in the saliva of patients with tobacco-related diseases including oral cancer, may potentially be used as biomarkers to indicate risks for the various diseases.

2.. Materials and Methods
=========================

2.1.. Collection of Whole Saliva
--------------------------------

Unstimulated whole saliva samples were collected from 24 healthy Malay male volunteers aged between 35 and 55 years (12 smokers and 12 non-smokers), with no history of diabetes, autoimmune diseases or exposure to radiation and chemotherapy. Characteristics of the participants who were considered heavy smokers in this study are shown in [Table 1](#t1-ijms-11-04488){ref-type="table"}. Saliva samples were collected with the volunteers' consent and approval granted by the Ethical committee (Institutional Review Board) of the Faculty of Dentistry, University of Malaya. Each subject answered a questionnaire concerning personal data, smoking and alcohol drinking habits, health or dental problems, oral hygiene habits, previous dental examinations, use of prescriptions, quantity and length of cigarette smoking. Unstimulated whole saliva was collected in the morning between 9 and 11 am to minimize the circadian effect, and subjects refrained from eating, drinking, smoking or performing any oral hygiene for at least 2 h prior to the collection. The difference between the mean flow rates of non-smokers (0.39 ± 0.04 mL/min) and smokers (0.42 ± 0.04 mL/min) was not statistically significant. Protease inhibitor cocktail was added to the saliva immediately after collection as previously described \[[@b43-ijms-11-04488]\]. To remove debris and cells, the saliva was centrifuged at 14,000 g for 20 min at 4 °C and the proteins were precipitated in 10% TCA/acetone/20 mM DTT. Saliva proteins were quantified using the Bradford protein assay kit (Bio-Rad, Hercules, USA) according to the manufacturer's instructions.

2.2.. Two-Dimensional Electrophoresis
-------------------------------------

Two-dimensional electrophoresis (2-DE) was performed as previously described \[[@b43-ijms-11-04488]\]. Saliva proteins (130 μg) were dissolved in rehydration buffer containing 7 M urea, 2 M thiourea, 4% CHAPS, 0.5% IPG buffer, 65 mM DTT and 0.002% bromophenol blue and applied onto 13 cm rehydrated precast immobilized drystrips pH 4--7 (GE Healthcare BioSciences, Uppsala, Sweden). Isoelectric focusing (IEF) for the first dimension and SDS-PAGE for the second dimension were performed as described previously \[[@b43-ijms-11-04488]\]. All samples were analyzed in triplicate.

2.3.. Silver Staining
---------------------

The 2-DE gels were developed by silver staining as described by Heukeshoven and Dernick \[[@b44-ijms-11-04488]\]. For mass spectrometry analyses, gels were stained with compatible silver staining with slight modifications according to Yan *et al*. \[[@b45-ijms-11-04488]\].

2.4.. Image Analysis
--------------------

The LabScan image scanner was used to capture and store images of 2-DE gels. The GE ImageMaster™ 2D Platinum Software version 7 was used to evaluate the protein profiles and perform protein analyses. To detect proteins that were differentially secreted in the saliva, the percentage volume contribution (% vol) of a protein spot, which refers to the spot volume of a protein expressed as a percentage of the total spot volume of all detected saliva proteins, was calculated. Data expressed this way are independent of variations attributed to protein loading and staining. The 2-DE profiles and relative spot intensities obtained were reproducible when performed in triplicate.

2.5.. In Gel Trypsin Digestion and Mass Spectrometry
----------------------------------------------------

Highly resolved protein spots were initially identified by visual comparison with previously published protein maps obtained from the human whole saliva \[[@b22-ijms-11-04488]--[@b26-ijms-11-04488]\]. The protein spots (1--2 mm diameter) were excised from silver-stained gels with pipette tips and kept hydrated in clean microfuge tubes containing Milli-Q water, prior to the in-gel digestion. Trypsin digestion and precise identification by mass spectrometry, using the MALDI-TOF/TOF instrument (Applied Biosystem 4800 Proteomic Analyzer), were performed as previously described \[[@b46-ijms-11-04488]\].

2.6.. Database Searches
-----------------------

Spectra were processed and analyzed by the Global Protein Server Workstation (Applied Biosystems), which uses the internal MASCOT (Matrix Science, London, UK) software for search of the peptide mass fingerprints and MS/MS data. Searches were performed against the Swiss-Prot database (Last update: October 23, 2008, containing 261513 sequences). Database search parameters were set as follows: The enzyme trypsin was used; up to one missed cleavage was allowed; variable modification included were carbamidomethylation of cysteine and oxidation of methionine; the mass tolerance for MS precursor ion and MS/MS fragment ion were 100 ppm and 0.2 Da, respectively; and only monoisotopic masses were included in the search.

2.7.. Statistical Analysis
--------------------------

All values are presented as mean ± S.E.M (standard error of the mean). The Student's t-test was used to analyze the significance of difference between non-smokers and smokers. The false discovery rate control was performed using the method of Benjamini and Hochberg \[[@b47-ijms-11-04488]\].

3.. Results
===========

[Figure 1](#f1-ijms-11-04488){ref-type="fig"} shows a typical 2-DE profile of saliva proteins separated between pH 4 and 7 in healthy non-smokers. This range of pH was chosen as our earlier 2-DE results performed at a pH range of 3 to 10 showed that most of the saliva proteins were located in the acidic region between pH 4 to 7. More than 120 spots were detected in the whole saliva samples using the 2-DE that was performed under the conditions of our study. Identities of 108 spots belonging to 57 different proteins were established by MS and database search ([Table 2](#t2-ijms-11-04488){ref-type="table"}). Some of these proteins, including polymeric immunoglobulin receptor (spots 3--9), carbonic anhydrase VI (spots 27--32), prolactin inducible proteins (spots 81--86), zinc-alpha-2-glycoprotein (spots 43 and 44), short palate, lung and nasal epithelium carcinoma-associated protein 1 (spots 58--61), cystatin S (spots 90 and 91) and lipocalin-1 (spots 87--89) were resolved in several isoforms and thus separated into distinct spots in the 2-DE gels.

Among the total of 57 saliva proteins, 35 had been previously identified using 2-DE \[[@b32-ijms-11-04488]--[@b39-ijms-11-04488]\], whereas 16, including plastin-2, actin-related protein-3, C3 complement precursor, macrophage capping protein, F actin capping protein, annexin A3, protein kinase C inhibitor protein-1, rho-GDP-dissociation inhibitor 1, rho-GDP-dissociation inhibitor 2, actin-related protein 2/3 complex subunit 5, alpha-1-acid glycoprotein 1, chloride intracellular channel protein 1, protein disulfide-isomerase, leukotriene A-4 hydrolase, IgGFc-binding protein and long palate, lung and nasal epithelium carcinoma-associated protein 1, were previously detected using liquid-based proteomics \[[@b21-ijms-11-04488],[@b23-ijms-11-04488]\]. The other six saliva proteins, eosinophil lysophospholipase, beta-microseminoprotein, coactosin-like protein, nucleoside diphosphate kinase A, calreticulin and synaptic vesicle membrane protein VAT-1, are reported for the first time by this study.

When 2-DE was performed on whole saliva samples of heavy smokers, the profiles obtained were similar to those from non-smokers. All 57 different proteins that were expressed in the saliva of the non-smokers were also detected in the saliva of the heavy smokers although the rates of presence of 16 proteins in the 2-DE profiles of the cigarette smokers were different from those of the non-smokers. When the 2-DE protein profiles obtained from the non- and heavy smokers were subjected to densitometry analysis, initially a significantly enhanced expression of seven proteins including polymeric immunoglobulin receptor, complement C3, α1-antitrypsin, calgranulin B, interleukin-1 receptor antagonist, thioredoxin and lipocalin-1, was detected between the two subject groups. However, only three of the proteins, *i.e.*, interleukin-1 receptor antagonist (+3 fold), thioredoxin (+2.5 fold) and lipocalin-1 (+4.4 fold) were found to be truly significant when the *p*-values were corrected for false significant results using the method of Benjamini and Hochberg \[[@b47-ijms-11-04488]\] ([Table 3](#t3-ijms-11-04488){ref-type="table"}). [Figure 2](#f2-ijms-11-04488){ref-type="fig"} demonstrates examples of 2-DE spot clusters of proteins whose levels were altered in the saliva obtained from the heavy smokers as compared to those of the non-smokers.

When the different isoforms of polymeric immunoglobulin receptor (spots 3--9), carbonic anhydrase VI (spots 27--32), prolactin inducible proteins (spots 81--86), zinc-alpha-2-glycoprotein (spots 43 and 44), short palate, lung and nasal epithelium carcinoma-associated protein 1 (spots 58--61) and cystatin S (spots 90 and 91) were similarly analyzed by densitometry, their volume distribution patterns were found to be consistent between the saliva of non-smokers and smokers. In contrast, the 2-DE volume distribution pattern for isoforms of lipocalin-1 in the saliva of non-smokers was different from that detected in the saliva of the heavy smokers ([Figure 3](#f3-ijms-11-04488){ref-type="fig"}). Among the seven isoforms analyzed, the isoform f was almost exclusive to the saliva of the smokers ([Table 4](#t4-ijms-11-04488){ref-type="table"}).

4.. Discussion
==============

Human whole saliva contains fluid from the salivary glands, gingival crevicular fluid, bronchiol and nasal secretions, desquamated epithelial cells, oral tissues, and very often, the components of blood, bacteria and viruses \[[@b48-ijms-11-04488]--[@b50-ijms-11-04488]\]. Therefore, whole saliva---in contrast to serum---is a hostile environment with proteins subjected to the effects of many host- and bacteria-derived enzymes. Some saliva proteins are synthesized in the salivary glands and subsequently subjected to intracellular processing including glycosylation, phosphorylation and proteolysis. Once the secretions enter the non-sterile oral environment, additional and continuous protein modifications by host- and bacteria-derived enzymes occur. This results in the possible generation of many modified proteins in whole saliva \[[@b51-ijms-11-04488]\].

The 2-DE profiles of proteins in whole saliva from healthy non-smokers that were generated in the present study showed strong resemblance to those that were previously reported \[[@b22-ijms-11-04488]--[@b26-ijms-11-04488]\]. Almost 90% of the protein spots that were highly resolved were eventually identified. The remaining spots were unidentifiable as the proteins generated low intensity spectra probably due to their low amounts, resistance to proteolytic cleavage, low recovery of digested peptides, and/or low efficiency in peptide ionization. Nevertheless, it is also possible that some of the unidentified proteins were of bacterial origin since the mouth is likely to harbor a lot of microorganisms.

In addition to the 35 human saliva proteins that have previously been established by other research groups using 2-DE \[[@b22-ijms-11-04488]--[@b26-ijms-11-04488]\], the present study detected the presence of 22 additional proteins. This is an important contribution to the human saliva proteome as a whole. Among the newly identified proteins (see [Table 2](#t2-ijms-11-04488){ref-type="table"}), nucleotide diphosphate kinase A, annexin A3, Rho-GDP-dissociation inhibitor 1, beta-microseminoprotein, chloride intracellular channel protein 1, protein disulfide-isomerase, calreticulin, peroxiredoxin-2, alpha-1-acid glycoprotein 1 and IgG Fc-binding protein are considered clinically interesting as they have been previously associated with cancer and other diseases \[[@b52-ijms-11-04488]--[@b61-ijms-11-04488]\].

The establishment of highly resolved 2-DE protein profiles enabled investigations on protein changes associated with cigarette smoking. Densitometry analyses on the 2-DE protein profiles obtained from the non- and heavy smokers showed differential abundance of interleukin-1 receptor antagonist, thioredoxin and lipocalin-1 between the saliva samples of the two subject groups ([Table 3](#t3-ijms-11-04488){ref-type="table"}). The three proteins have good potential to be used as non-specific complementary biomarkers for the adverse effects of smoking although this requires further evaluation and correlative studies. Some of the proteins may be used as risk indicators for inflammatory and chronic diseases that are associated with smoking as they have been shown to be of increased levels in the saliva of the patients. In the case of lipocalin-1, the isoform distribution pattern detected was also found to differ between smokers and non-smokers. This suggests that the carbohydrate moieties of lipocalin-1 of the heavy cigarette smokers were different from those of the non-smokers and that they may be differently glycosylated or modified. However, this remains to be further established.

Despite being distinctly categorized according to their primary biological roles \[[@b62-ijms-11-04488]\], the three saliva proteins that were altered in abundance reflect the body's overall response to the damaging effects of heavy smoking. The high levels of IL-1 receptor antagonist in the saliva of the heavy smokers detected in this study reflect an anti-inflammatory response in the oral cavities of the smokers. Increased generation of the proteins in smokers may be induced by the proinflammatory cytokines that were promoted by oxidative stress \[[@b63-ijms-11-04488]--[@b65-ijms-11-04488]\]. An imbalance between IL-1 receptor antagonist and IL-1 has been hypothesized to play a role in the pathogenesis of various inflammatory diseases \[[@b65-ijms-11-04488]\].

Lipocalin-1 and thioredoxin are proteins most likely involved in the response to stress in relation to tissue damage. The high levels of lipocalin-1 and thioredoxin in the cigarette smokers' saliva may reflect their function as an oxidative stress-induced scavenger against toxic and pro-inflammatory lipids \[[@b66-ijms-11-04488]--[@b68-ijms-11-04488]\]. Lipocalin-1 had been suggested to be a cysteine proteinase inhibitor \[[@b67-ijms-11-04488]\] and may have a role in the control of inflammatory processes in oral tissues. Thioredoxin, on the other hand, was shown to modulate remodeling factors in response to the cigarette smoke \[[@b68-ijms-11-04488]\]. Increased secretion of thioredoxin had been previously demonstrated in the saliva of patients with oral cancer \[[@b32-ijms-11-04488]\].

5.. Conclusion
==============

Comparative proteomics analysis of human saliva samples from subjects who were considered heavy cigarette smokers and those who did not smoke detected altered abundance of interleukin-1 receptor antagonist, thioredoxin and lipocalin-1, as well as a change in the isoform distribution patterns of lipocalin-1. These proteins may be used as early biomarkers to indicate risks of tobacco-related diseases.
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![Typical 2-DE profile of precipitated saliva proteins obtained from non-smokers. A total of 108 protein spots (circled and numbered) were identified by mass spectrometry and database search (please refer to [Table 2](#t2-ijms-11-04488){ref-type="table"}). Acid side of 2-DE gel is to the left and relative molecular mass declines from the top.](ijms-11-04488f1){#f1-ijms-11-04488}

![Cropped images of saliva proteins in the 2-DE gels of non-smokers and smokers. Representative gels of two differentially expressed saliva proteins are shown. Spot numbers are those referred to in [Table 2](#t2-ijms-11-04488){ref-type="table"}.](ijms-11-04488f2){#f2-ijms-11-04488}

![Cropped images of lipocalin-1 isoform spots in the 2-DE gels of non-smokers and smokers. Six representative gels are shown. The isoform spots a to g are marked in the gels (only represented in one of the images so as not to affect image display). Detailed densitometry analysis of the isoform spots is demonstrated in [Table 4](#t4-ijms-11-04488){ref-type="table"}.](ijms-11-04488f3){#f3-ijms-11-04488}

###### 

Demographics and smoking history of smoker subjects.

  **Subject[(a)](#tfn1-ijms-11-04488){ref-type="table-fn"}**   **Age**   **Cigarettes/Day**   **Smoking Duration[(b)](#tfn2-ijms-11-04488){ref-type="table-fn"}**   **Stick-year[(c)](#tfn3-ijms-11-04488){ref-type="table-fn"}**
  ------------------------------------------------------------ --------- -------------------- --------------------------------------------------------------------- ---------------------------------------------------------------
  1                                                            35        20                   15                                                                    300
  2                                                            36        14                   23                                                                    322
  3                                                            38        20                   15                                                                    300
  4                                                            51        14                   20                                                                    280
  5                                                            36        14                   15                                                                    210
  6                                                            54        20                   30                                                                    600
  7                                                            38        20                   17                                                                    340
  8                                                            54        30                   30                                                                    900
  9                                                            39        20                   20                                                                    400
  10                                                           39        20                   25                                                                    500
  11                                                           48        24                   17                                                                    408
  12                                                           40        14                   15                                                                    210

All subjects were male and of Malay ethnicity;

Duration in years since first started smoking;

Stick-year of exposure is in accordance to the Brickman index, which is the number of cigarettes smoked per day multiplied by the smoking duration.

###### 

Identification of saliva proteins by mass spectrometry.

  **Accession No. [(a)](#tfn4-ijms-11-04488){ref-type="table-fn"}**   **Protein**                                                                                                            **Spot No.[(b)](#tfn5-ijms-11-04488){ref-type="table-fn"}**   **MASCOT Score**   **No. of Peptides Hit**   **Sequence Coverage**   **Ref.**
  ------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------- ------------------ ------------------------- ----------------------- ---------------------------------------------------------------------
  P02787                                                              Serotransferrin                                                                                                        1                                                             89                 10                        9                       \[[@b22-ijms-11-04488],[@b23-ijms-11-04488],[@b25-ijms-11-04488]\]
                                                                      2                                                                                                                      78                                                            16                 8                                                 
  P01833                                                              Polymeric immunoglobulin receptor                                                                                      3                                                             282                9                         8                       \[[@b22-ijms-11-04488]--[@b26-ijms-11-04488]\]
  4                                                                   111                                                                                                                    11                                                            33                                                                   
                                                                      5                                                                                                                      99                                                            17                 27                                                
                                                                      6                                                                                                                      240                                                           7                  22                                                
                                                                      7                                                                                                                      246                                                           20                 55                                                
                                                                      8                                                                                                                      169                                                           12                 32                                                
                                                                      9                                                                                                                      120                                                           18                 28                                                
  Q9Y6R7                                                              IgGFc-binding protein                                                                                                  10                                                            645                10                        2                       Npd
  Q8TDL5                                                              [\*](#tfn6-ijms-11-04488){ref-type="table-fn"}Long palate, lung and nasal epithelium carcinoma-associated protein 1    11                                                            187                4                         11                      Npd
  P09960                                                              [\*](#tfn6-ijms-11-04488){ref-type="table-fn"}Leukotriene A-4 hydrolase                                                12                                                            376                6                         14                      Npd
  P02768                                                              Serum albumin                                                                                                          13                                                            98                 3                         5                       \[[@b22-ijms-11-04488]--[@b26-ijms-11-04488]\]
                                                                      14                                                                                                                     122                                                           5                  7                                                 
  P04745                                                              Human salivay α-amylase                                                                                                15                                                            101                15                        27                      \[[@b22-ijms-11-04488]--[@b26-ijms-11-04488]\]
  P08107                                                              Heat shock 70 kDa protein 1                                                                                            16                                                            572                8                         14                      \[[@b23-ijms-11-04488]\]
  P13796                                                              Plastin-2                                                                                                              17                                                            555                32                        16                      Npd
  P07237                                                              [\*](#tfn6-ijms-11-04488){ref-type="table-fn"}Protein disulfide-isomerase                                              18                                                            636                13                        27                      Npd
  P02774                                                              Vitamin D-binding protein precursor                                                                                    19                                                            741                11                        32                      \[[@b27-ijms-11-04488]\]
  20                                                                  575                                                                                                                    10                                                            27                                                                   
  P01009                                                              Alpha-1-antitrypsin                                                                                                    21                                                            211                8                         10                      \[[@b25-ijms-11-04488]\]
                                                                      22                                                                                                                     112                                                           6                  12                                                
                                                                      23                                                                                                                     99                                                            5                  18                                                
  P61158                                                              Actin-related protein 3                                                                                                24                                                            327                13                        17                      Npd
  P50395                                                              [\*](#tfn6-ijms-11-04488){ref-type="table-fn"}Rab GDP dissociation inhibitor beta                                      25                                                            363                15                        19                      \[[@b28-ijms-11-04488]\]
  P06733                                                              Alpha-enolase                                                                                                          26                                                            735                11                        33                      \[[@b22-ijms-11-04488],[@b23-ijms-11-04488],[@b26-ijms-11-04488]\]
  P23280                                                              Carbonic anhydrase VI                                                                                                  27                                                            290                15                        19                      \[[@b22-ijms-11-04488],[@b23-ijms-11-04488]\]
                                                                      28                                                                                                                     90                                                            4                  4                                                 
                                                                      29                                                                                                                     303                                                           11                 40                                                
                                                                      30                                                                                                                     488                                                           32                 48                                                
                                                                      31                                                                                                                     79                                                            4                  8                                                 
                                                                      32                                                                                                                                                                                                                                                        
  P30740                                                              [\*](#tfn6-ijms-11-04488){ref-type="table-fn"}Leukocyte elastase inhibitor                                             33                                                            374                12                        19                      \[[@b29-ijms-11-04488]\]
  34                                                                  315                                                                                                                    10                                                            16                                                                   
  Q99536                                                              [\*\*](#tfn7-ijms-11-04488){ref-type="table-fn"}Synaptic vesicle membrane protein VAT-1                                35                                                            76                 2                         4                       Npd
  P40121                                                              Macrophage-capping protein                                                                                             36                                                            579                16                        20                      Npd
  P02675                                                              Fibrinogen beta chain                                                                                                  37                                                            676                12                        26                      \[[@b23-ijms-11-04488],[@b25-ijms-11-04488]\]
                                                                      38                                                                                                                     554                                                           16                 36                                                
                                                                      39                                                                                                                     467                                                           15                 20                                                
  P00738                                                              Haptoglobin                                                                                                            40                                                            518                10                        21                      \[[@b28-ijms-11-04488]\]
  P37837                                                              [\*](#tfn6-ijms-11-04488){ref-type="table-fn"}Transaldolase                                                            41                                                            60                 8                         15                      \[[@b28-ijms-11-04488]\]
                                                                      42                                                                                                                     77                                                            6                  13                                                
  P25311                                                              Zinc-alpha-2-glycoprotein                                                                                              43                                                            246                16                        28                      \[[@b22-ijms-11-04488]--[@b26-ijms-11-04488]\]
  44                                                                  285                                                                                                                    11                                                            20                                                                   
  P60709                                                              Actin, cytoplasmic 1                                                                                                   45                                                            230                3                         15                      \[[@b23-ijms-11-04488],[@b25-ijms-11-04488]\]
                                                                      46                                                                                                                     188                                                           4                  15                                                
  P27797                                                              [\*\*](#tfn7-ijms-11-04488){ref-type="table-fn"}Calreticulin                                                           47                                                            651                10                        27                      Npd
  P01024                                                              Complement C3                                                                                                          48                                                            330                15                        6                       Npd
                                                                      49                                                                                                                     332                                                           14                 5                                                 
  P63261                                                              Actin, cytoplasmic 2                                                                                                   50                                                            285                11                        20                      \[[@b23-ijms-11-04488]\]
  P60709                                                              Actin, cytoplasmic 1                                                                                                   51                                                            243                5                         14                      \[[@b23-ijms-11-04488],[@b25-ijms-11-04488]\]
  P52907                                                              F-actin-capping protein subunit alpha-1                                                                                52                                                            274                6                         16                      Npd
  P25311                                                              Zinc-alpha-2-glycoprotein                                                                                              53                                                            82                 3                         10                      \[[@b22-ijms-11-04488]--[@b26-ijms-11-04488]\]
  P12429                                                              Annexin A3                                                                                                             54                                                            331                8                         14                      Npd
  P00738                                                              Haptoglobin                                                                                                            55                                                            627                12                        24                      \[[@b28-ijms-11-04488]\]
  P01876                                                              Ig alpha-1 chain C region                                                                                              56                                                            274                5                         17                      \[[@b22-ijms-11-04488]--[@b24-ijms-11-04488],[@b26-ijms-11-04488]\]
  P30740                                                              [\*](#tfn6-ijms-11-04488){ref-type="table-fn"}Leukocyte elastase inhibitor                                             57                                                            417                20                        30                      \[[@b29-ijms-11-04488]\]
  Q96DR5                                                              [\*](#tfn6-ijms-11-04488){ref-type="table-fn"}Short palate, lung and nasal epithelium carcinoma-associated protein 2   58                                                            141                4                         15                      \[[@b22-ijms-11-04488]\]
  59                                                                  119                                                                                                                    5                                                             18                                                                   
  60                                                                  293                                                                                                                    20                                                            68                                                                   
                                                                      61                                                                                                                                                                                                                                                        
  O00299                                                              [\*](#tfn6-ijms-11-04488){ref-type="table-fn"}Chloride intracellular channel protein 1                                 62                                                            561                9                         52                      Npd
  P63104                                                              Protein kinase C inhibitor protein-1(14-3-3 protein zeta/delta)                                                        63                                                            101                4                         12                      Npd
  P01834                                                              Ig kappa chain C region                                                                                                64                                                            101                4                         33                      \[[@b23-ijms-11-04488]--[@b26-ijms-11-04488]\]
  P01591                                                              Immunoglobulin J chain                                                                                                 65                                                            241                11                        32                      \[[@b22-ijms-11-04488],[@b24-ijms-11-04488],[@b25-ijms-11-04488]\]
  P52565                                                              Rho GDP-dissociation inhibitor 1                                                                                       66                                                            356                13                        30                      Npd
  P52566                                                              [\*](#tfn6-ijms-11-04488){ref-type="table-fn"}Rho GDP-dissociation inhibitor 2                                         67                                                            173                9                         31                      Npd
  P09211                                                              Glutathione S Transferase                                                                                              68                                                            201                6                         22                      \[[@b22-ijms-11-04488]--[@b24-ijms-11-04488],[@b26-ijms-11-04488]\]
                                                                      69                                                                                                                     493                                                           19                 61                                                
  P32119                                                              Peroxiredoxin-2                                                                                                        70                                                            264                6                         27                      \[[@b28-ijms-11-04488]\]
  P02763                                                              Alpha-1-acid glycoprotein 1                                                                                            71                                                            317                6                         27                      Npd
                                                                      72                                                                                                                     137                                                           4                  17                                                
  P18510                                                              Interleukin-1 receptor antagonist protein                                                                              73                                                            148                6                         15                      \[[@b22-ijms-11-04488],[@b24-ijms-11-04488]\]
  P00738                                                              Haptoglobin                                                                                                            74                                                            358                6                         22                      \[[@b28-ijms-11-04488]\]
                                                                      75                                                                                                                     491                                                           7                  20                                                
                                                                      76                                                                                                                     439                                                           8                  22                                                
  P15531                                                              [\*\*](#tfn7-ijms-11-04488){ref-type="table-fn"}Nucleoside diphosphate kinase A                                        77                                                            132                6                         25                      Npd
  P52566                                                              Rho GDP-dissociation inhibitor 2                                                                                       78                                                            185                4                         32                      Npd
  O15511                                                              Actin-related protein 2/3 complex subunit 5                                                                            79                                                            69                 2                         7                       Npd
  P12273                                                              Prolactin-inducible protein                                                                                            80                                                            385                6                         45                      \[[@b22-ijms-11-04488]--[@b25-ijms-11-04488]\]
                                                                      81                                                                                                                     116                                                           32                 6                                                 
                                                                      82                                                                                                                     375                                                           5                  44                                                
                                                                      83                                                                                                                     365                                                           6                  45                                                
                                                                      84                                                                                                                     410                                                           6                  45                                                
                                                                      85                                                                                                                     413                                                           7                  54                                                
                                                                      86                                                                                                                     279                                                           5                  45                                                
  P31025                                                              [\*](#tfn6-ijms-11-04488){ref-type="table-fn"}Lipocalin-1                                                              87                                                            169                5                         18                      \[[@b22-ijms-11-04488],[@b24-ijms-11-04488]\]
                                                                      88                                                                                                                     168                                                           3                  17                                                
                                                                      89                                                                                                                     213                                                           4                  21                                                
  P01036                                                              [\*](#tfn6-ijms-11-04488){ref-type="table-fn"}Cystatin S                                                               90                                                            535                15                        62                      \[[@b22-ijms-11-04488]--[@b24-ijms-11-04488],[@b26-ijms-11-04488]\]
                                                                      91                                                                                                                     444                                                           8                  58                                                
  P09228                                                              [\*](#tfn6-ijms-11-04488){ref-type="table-fn"}Cystatin SA                                                              92                                                            437                7                         64                      \[[@b22-ijms-11-04488]--[@b26-ijms-11-04488]\]
  P10599                                                              Thioredoxin                                                                                                            93                                                            88                 4                         16                      \[[@b21-ijms-11-04488]\]
                                                                      94                                                                                                                     111                                                           3                  15                                                
  P12273                                                              Prolactin-inducible protein                                                                                            95                                                            413                7                         54                      \[[@b22-ijms-11-04488]--[@b25-ijms-11-04488]\]
  P02766                                                              Transthyretin                                                                                                          96                                                            80                 3                         33                      \[[@b28-ijms-11-04488],[@b33-ijms-11-04488]\]
  Q14019                                                              [\*\*](#tfn7-ijms-11-04488){ref-type="table-fn"}Coactosin-like protein                                                 97                                                            379                8                         60                      Npd
  P08118                                                              [\*\*](#tfn7-ijms-11-04488){ref-type="table-fn"}Beta-microseminoprotein                                                98                                                            119                2                         8                       Npd
  P02766                                                              Transthyretin                                                                                                          99                                                            269                7                         40                      \[[@b28-ijms-11-04488],[@b33-ijms-11-04488]\]
  Q01469                                                              [\*](#tfn6-ijms-11-04488){ref-type="table-fn"}Fatty acid-binding protein, epidermal                                    100                                                           219                6                         47                      \[[@b22-ijms-11-04488]--[@b24-ijms-11-04488],[@b29-ijms-11-04488]\]
  P01036                                                              [\*](#tfn6-ijms-11-04488){ref-type="table-fn"}Cystatin S                                                               101                                                           192                4                         37                      \[[@b22-ijms-11-04488]--[@b24-ijms-11-04488],[@b26-ijms-11-04488]\]
  P06702                                                              Calgranulin-B                                                                                                          102                                                           296                6                         51                      \[[@b22-ijms-11-04488],[@b24-ijms-11-04488],[@b26-ijms-11-04488]\]
  P01040                                                              Cystatin-A                                                                                                             103                                                           42                 1                         18                      \[[@b22-ijms-11-04488],[@b25-ijms-11-04488],[@b26-ijms-11-04488]\]
  P06702                                                              Calgranulin-B                                                                                                          104                                                           395                7                         63                      \[[@b22-ijms-11-04488],[@b24-ijms-11-04488],[@b26-ijms-11-04488]\]
  P28325                                                              [\*](#tfn6-ijms-11-04488){ref-type="table-fn"}Cystatin D                                                               105                                                           172                6                         34                      \[[@b22-ijms-11-04488],[@b24-ijms-11-04488]\]
  Q01469                                                              [\*](#tfn6-ijms-11-04488){ref-type="table-fn"}Fatty acid-binding protein, epidermal                                    106                                                           347                8                         52                      \[[@b22-ijms-11-04488]--[@b24-ijms-11-04488],[@b29-ijms-11-04488]\]
  Q05315                                                              [\*\*](#tfn7-ijms-11-04488){ref-type="table-fn"}Eosinophil lysophospholipase                                           107                                                           108                3                         9                       Npd
  P01037                                                              [\*](#tfn6-ijms-11-04488){ref-type="table-fn"}Cystatin SN                                                              108                                                           293                20                        68                      \[[@b22-ijms-11-04488]--[@b26-ijms-11-04488]\]

Accession no. are in accordance to Swiss-Prot;

Spot numbers are those referred to in [Figures 1](#f1-ijms-11-04488){ref-type="fig"} and [2](#f2-ijms-11-04488){ref-type="fig"} and identified by MS/MS; Npd---proteins not previously detected in the saliva proteome using 2-DE;

Proteins found only in saliva and not in plasma;

Proteins detected for the first time in the saliva proteome of this study.

###### 

Densitometry analysis of saliva proteins and their rates of presence in 2-DE profiles.

  **Protein**                                                              **Non-smokers**   **Smokers**                        
  ------------------------------------------------------------------------ ----------------- ------------- --------------- ---- -------
  **1: Energy/Metabolism**                                                                                                      
  Amylase                                                                  14.15 (±0.54)     12            12.72 (±0.85)   12   0.168
  Carbonic anhydrase VI                                                    1.48 (±0.17)      12            1.07 (±0.14)    12   0.077
  Zinc-alpha-2-glycoprotein                                                1.02 (±0.09)      12            1.09 (±0.13)    12   0.673
  Fatty acid-binding protein, epidermal                                    0.08 (±0.01)      12            0.12 (±0.02)    12   0.111
  Transaldolase                                                            0.04 (±0.01)      12            0.04 (±0.01)    12   0.543
  Alpha-enolase                                                            0.06 (±0.02)      10            0.10 (±0.02)    12   0.183
  **2: Defence/Immune response**                                                                                                
  Polymeric immunoglobulin receptor                                        4.58 (±0.12)      12            3.57 (±0.40)    12   0.024
  Immunoglobulin J chain                                                   0.38 (±0.06)      12            0.41 (±0.06)    12   0.305
  Interleukin-1 receptor antagonist protein                                0.01 (±0.00)      7             0.04 (±0.01)    11   0.004
  Prolactin-inducible protein                                              2.27 (±0.20)      12            2.35 (±0.23)    12   0.787
  Short palate, lung and nasal epithelium carcinoma-associated protein 2   1.22 (±0.18)      11            1.42 (±0.18)    12   0.456
  Alpha-1-acid glycoprotein 1                                              0.01 (±0.00)      2             0.02 (±0.01)    5    0.159
  **3: Protein degradation inhibitor**                                                                                          
  α~1~-Antitrypsin                                                         0.02 (±0.01)      6             0.05 (±0.01)    8    0.027
  Cystatin A                                                               0.08 (±0.02)      12            0.09 (±0.03)    12   0.620
  Cystatin S                                                               0.04 (±0.01)      12            0.05 (±0.01)    12   0.775
  Cystatin SA                                                              0.28 (±0.05)      12            0.27 (±0.07)    12   0.916
  Cystatin SN                                                              0.28 (±0.06)      12            0.30 (±0.04)    12   0.744
  Cystatin D                                                               0.12 (±0.02)      12            0.12 (±0.02)    11   0.769
  Leukocyte elastase inhibitor                                             0.10 (±0.01)      12            0.10 (±0.01)    12   0.922
  **4: Cell adhesion/communication**                                                                                            
  Calgranulin B                                                            0.13 (±0.01)      12            0.21 (±0.04)    12   0.032
  **5: Protein folding/repair**                                                                                                 
  Heat shock 70 kDa protein 1                                              0.06 (±0.01)      12            0.05 (±0.01)    12   0.818
  **6: Redox**                                                                                                                  
  Thioredoxin                                                              0.03 (±0.00)      1             0.07 (±0.02)    8    0.001
  Peroxiredoxin-2                                                          0.01 (±0.01)      3             0.02 (±0.01)    7    0.617
  **7: Signaling**                                                                                                              
  Complement C3 precursor                                                  0.00 (±0.00)      3             0.01 (±0.00)    9    0.012
  Glutathione-S Transferase                                                0.10 (±0.01)      12            0.12 (±0.02)    12   0.444
  Rho GDP-dissociation inhibitor 1                                         0.14 (±0.03)      3             0.15 (±0.03)    3    0.557
  Rho GDP-dissociation inhibitor 2                                         0.03 (±0.01)      10            0.04 (±0.01)    12   0.327
  Protein kinase C inhibitor protein-1                                     0.11 (±0.03)      7             0.17 (±0.05)    11   0.282
  Annexin A3                                                               0.07 (±0.02)      11            0.00 (±0.01)    6    0.088
  **8: Structural/cytoskeletal**                                                                                                
  [f]{.smallcaps}-actin-capping protein subunit alpha-1                    0.02 (±0.01)      4             0.03 (±0.01)    8    0.521
  Macrophage-capping protein                                               0.03 (±0.01)      7             0.02 (±0.00)    9    0.261
  [l]{.smallcaps}-plastin                                                  0.11 (±0.01)      12            0.09 (±0.01)    12   0.376
  **9: Transport**                                                                                                              
  Lipocalin-1                                                              0.15 (±0.05)      8             0.65 (±0.13)    12   0.001
  Haptoglobin                                                              0.06 (±0.01)      11            0.07 (±0.01)    12   0.694
  Transthyretin                                                            0.07 (±0.01)      12            0.10 (±0.02)    12   0.108
  Serum albumin                                                            1.63 (±0.14)      12            1.71 (±022)     12   0.758

volume of a protein expressed as a percentage of the total spot volume of all proteins;

rate of presence of the protein spots in the 12 2-DE profiles that were analyzed;

*p*-values of less than 0.0068 (*p* \< 0.0068) were considered statistically significant when the false discovery rate procedure of Benjamini and Hochberg \[[@b47-ijms-11-04488]\] was performed to the data set.

###### 

Densitometry analysis of lipocalin-1 isoforms and their rates of presence in 2-DE profiles.

  **Isoform Spot[(a)](#tfn11-ijms-11-04488){ref-type="table-fn"}**   **Non-smokers**   **Smokers**   ***p***   **Fold Change[(d)](#tfn14-ijms-11-04488){ref-type="table-fn"}**           
  ------------------------------------------------------------------ ----------------- ------------- --------- ----------------------------------------------------------------- ------- -------
  a                                                                  0.056             8             0.195     12                                                                0.005   +3.5
  b                                                                  0.007             4             0.150     10                                                                0.000   +21.4
  c                                                                  0.085             11            0.305     12                                                                0.012   +3.7
  d                                                                  0.013             5             0.108     11                                                                0.012   +8.3
  e                                                                  0.006             4             0.069     9                                                                 0.038   +11.5
  f                                                                  0.003             1             0.089     6                                                                 0.031   +29.7
  g                                                                  0.110             12            0.316     12                                                                0.018   +2.9

isoforms of lipocalin-1 as depicted in [Figure 3](#f3-ijms-11-04488){ref-type="fig"};

volume of a protein expressed as a percentage of the total spot volume of all proteins;

rate of presence of the protein spots in the 12 2-DE profiles that were analyzed;

fold change is the ratio of %vol of smokers to non-smokers.
